One email when new issuers, new metrics and new articles land. Double opt-in, zero spam, one-click unsubscribe.
Invesco S&P World Health Care ESG UCITS ETF Acc tracks the issuer-declared index: S&P World ESG Enhanced Health Care Index. The declared annual cost (TER) is 0.18%, plus 0.02% in transaction costs estimated by the issuer in the KID. Replication is physical replication (it buys the index constituents); income is accumulated and reinvested in the fund. The fund has assets of about 10 million euro, was launched on 12 April 2023 and is domiciled in Ireland.
Investment objective: The objective of the Fund is to achieve the net total return performance of the S&P World ESG Enhanced Health Care Index (the "Index"), less fees, expenses and transaction costs. Investment approach: The Fund is a passively managed ETF. To achieve the investment objective, the Fund will, as far as possible and practicable, hold all the securities in the Index in their respective weightings. The Fund may use derivative instruments for the purposes of managing risk, reducing costs, generating additional capital or income. The Fund may engage in securities lending, whereby 90% of the revenues arising from securities lending will be returned to the Fund and 10% of the revenues will be retained by the securities lending agent. The Fund may be exposed to the risk of the borrower defaulting on its obligation to return the securities at the end of the loan period and of being unable to sell the collateral provided to it if the borrower defaults. The Fund is an Article 8 Fund (it promotes environmental and/or social characteristics) for the purposes of Regulation (EU) 2019/2088 of the European Parliament and of the Council of 27 November 2019 on sustainability‐related disclosures in the financial services sector ("SFDR"). The Fund’s base currency is USD. Dividend Policy: This Share Class does not pay you income, but instead reinvests it to grow your capital, in line with its stated objectives. The Index: The Index is designed to measure the performance of large and mid-capitalisation Health Care companies in developed markets and seeks to enhance its ESG profile and reduce its carbon footprint, relative to the S&P World Health Care Index (the "Parent Index"). The Index has been constructed by excluding from the Parent Index, on a quarterly basis, securities that: 1) are involved (according to the Index Provider’s criteria) in business activities in tobacco, controversial weapons, oil sands, small arms, military contracting and thermal coal, and 2) are classified as Non-Compliant according to the United Nations Global Compact (UNGC) principles. Securities are also excluded from the Parent Index, on a semi-annual basis, that: 1) do not have a S&P Global ESG Score; (2) do not have carbon intensity data; (3) have an S&P Global ESG Score that falls within the lowest 20% of ESG scores by stock count of the Parent Index; and (4) have carbon intensity levels that rank in the worst 10% of companies by free-float market cap per GICS Industry Group of the Parent Index and in the worst 10% of companies by freefloat market cap in the S&P World Index. Involvement and revenue thresholds are defined by the Index provider. Further information in relation to any revenue thresholds and controversy scoring criteria, can be obtained from the Index Practical Information Fund Depositary: The Bank of New York Mellon SA/NV, Dublin Branch, Riverside Two, Sir John Rogerson’s Quay, Grand Canal Dock, Dublin 2, D02 KV60, Ireland. Find out more: This document is specific to the Fund. Further information about the Fund can be obtained from the supplement, the prospectus, annual and interim reports. The prospectus, annual and interim reports are prepared for the Umbrella Fund, of which the Fund is a sub-fund. These documents are available free of charge in English. They can be obtained along with other information, such as share prices, at https://etf.invesco.com (select your country and navigate to the Documents section on the product page), or by calling +353 1 439 8000. The assets of the Fund are segregated as a matter of Irish law and as such, in Ireland, the assets of one sub-fund will not be available to satisfy the liabilities of another sub-fund. This position may be considered differently by the courts in jurisdictions outside of Ireland. Subject to satisfying certain criteria as set out in the prospectus, investors may be able to exchange their investment in the Fund for shares in another sub-fund of the Umbrella which is being offered at that time.
Keep reading the KID section ▾
Redemption and Dealing of Shares:The Fund's shares are listed on one or more Stock Exchange(s). Investors can buy or sell shares daily through an intermediary directly or on Stock Exchange(s) on which the shares are traded. In exceptional circumstances investors will be permitted to redeem their shares directly from the Umbrella Fund in accordance with the redemption procedures set out in the prospectus, subject to any applicable laws and relevant charges.
Intended Retail InvestorThe Fund is intended for investors aiming for long term capital growth, who may not have specific financial expertise but are able to make an informed investment decision based on this document, the supplement, and the prospectus, have a risk appetite consistent with the risk indicator displayed below and understand that there is no capital guarantee or protection (100% of capital is at risk).
| From the peak of | Trough | Depth | Back to break-even | Days underwater |
|---|---|---|---|---|
| 30 Aug 2024 | 14 May 2025 | -19.64% | 07 Jan 2026 | 495 |
| 27 Feb 2026 | 29 Apr 2026 | -12.83% | 28 Jul 2026 | 151 |
| 13 Apr 2023 | 27 Oct 2023 | -8.26% | 13 Dec 2023 | 244 |
| 28 Mar 2024 | 17 Apr 2024 | -5.59% | 15 May 2024 | 48 |
| 25 Aug 2026 | 31 Aug 2026 | -3.51% | ongoing | 8 |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sept | Oct | Nov | Dec | Year | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 0.8 | 3.4 | -9.1 | -1.6 | 2.6 | 4.2 | 2.1 | 4.1 | 1.1 | 7.2 | |||
| 2025 | 6.0 | 2.1 | -2.2 | -2.2 | -5.3 | 1.4 | -1.1 | 4.3 | 0.7 | 3.0 | 9.1 | -0.5 | 15.4 |
| 2024 | 2.9 | 1.6 | 2.4 | -3.1 | 2.9 | 2.9 | 2.4 | 6.3 | -3.6 | -4.5 | -1.8 | -5.9 | 1.6 |
| 2023 | -4.3 | 2.1 | 1.8 | -0.5 | -2.0 | -3.0 | 5.2 | 4.3 | 3.1 |
| Year | Fund | Index | Difference |
|---|---|---|---|
| 2025 | +15.45% | +15.40% | +0.04% |
| 2024 | +1.65% | +1.60% | +0.05% |
| Last year | Last 3 years | Full history | |
|---|---|---|---|
| Volatility (ann.) | 16.06% | 14.50% | 14.19% |
| Max drawdown | -12.17% | -21.55% | -21.55% |
| Sharpe | 1.14 | 0.31 | 0.25 |
| Sortino | 1.89 | 0.44 | 0.36 |
| Exchange | Ticker | Trading since |
|---|---|---|
| Borsa Italiana (ETFplus) | WDHE | 17 Apr 2023 |
| Börse Düsseldorf | WH2E | 17 Apr 2023 |
| Börse Frankfurt | WH2E | 17 Apr 2023 |
| Börse Hamburg | WH2E | 3 Jul 2023 |
| Börse Hannover | WH2E | 9 Dec 2024 |
| Börse München / gettex | WH2E | 2 May 2023 |
| Börse Stuttgart | WH2E | 26 Apr 2023 |
| Tradegate Exchange | WH2E | 28 Apr 2023 |
| Xetra (Deutsche Börse) | WH2E | 17 Apr 2023 |